Trastuzumab Emtansine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB05773 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | normal breast-like subtype of breast carcinoma | KG + DL |
| 2 | progesterone-receptor positive breast cancer | KG + DL |
| 3 | progesterone-receptor negative breast cancer | KG + DL |
| 4 | breast tumor luminal A or B | KG + DL |
| 5 | synovium cancer | KG + DL |
| 6 | tenosynovial giant cell tumor | KG + DL |
| 7 | tenosynovial giant cell tumor, localized type | KG + DL |
| 8 | malignant giant cell tumor | KG + DL |
| 9 | human herpesvirus 8-related tumor | KG + DL |
| 10 | ectomesenchymoma | KG + DL |
| 11 | malignant cutaneous granular cell skin tumor | KG + DL |
| 12 | benign neoplasm of tongue | KG + DL |
| 13 | cervical neuroblastoma | KG + DL |
| 14 | schwannoma of jugular foramen | KG + DL |
| 15 | benign neoplasm of hypopharynx | KG + DL |
| 16 | benign neoplasm of buccal mucosa | KG + DL |
| 17 | jugular foramen meningioma | KG + DL |
| 18 | neoplasm of major salivary gland | KG + DL |
| 19 | kidney pelvis sarcomatoid transitional cell carcinoma | KG + DL |
| 20 | inner ear neoplasm | KG + DL |
| 21 | nasal cavity inverting papilloma | KG + DL |
| 22 | benign neoplasm of floor of mouth | KG + DL |
| 23 | prostatic urethra urothelial carcinoma | KG + DL |
| 24 | benign neoplasm of salivary gland | KG + DL |
| 25 | benign neoplasm of nasal cavity | KG + DL |
| 26 | epiglottis neoplasm | KG + DL |
| 27 | vestibulocochlear nerve neoplasm | KG + DL |
| 28 | benign neoplasm of oral cavity | KG + DL |
| 29 | infiltrating bladder urothelial carcinoma sarcomatoid variant | KG + DL |
| 30 | abducens nerve neoplasm | KG + DL |
| 31 | trochlear nerve neoplasm | KG + DL |
| 32 | facial nerve neoplasm | KG + DL |
| 33 | spinal accessory nerve neoplasm | KG + DL |
| 34 | skull base neoplasm | KG + DL |
| 35 | giant cell tumor | KG + DL |
| 36 | neoplasm of minor salivary gland | KG + DL |
| 37 | vagus nerve paraganglioma | KG + DL |
| 38 | benign neoplasm of ear | KG + DL |
| 39 | external ear neoplasm | KG + DL |
| 40 | malignant tenosynovial giant cell tumor | KG + DL |
| 41 | oculomotor nerve neoplasm | KG + DL |
| 42 | renal pelvis papillary urothelial carcinoma | KG + DL |
| 43 | nasopharyngeal teratoma | KG + DL |
| 44 | ocular cancer | KG + DL |
| 45 | Keratocystic odontogenic tumor | KG + DL |
| 46 | lymphangiomyoma | KG + DL |
| 47 | cystic neoplasm | KG + DL |
| 48 | benign PEComa | KG + DL |
| 49 | middle ear neuroendocrine tumor | KG + DL |
| 50 | malignant ear neoplasm | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.